These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The cardiovascular risk of tiotropium: is it real? Cazzola M; Calzetta L; Matera MG Expert Opin Drug Saf; 2010 Sep; 9(5):783-92. PubMed ID: 20565229 [TBL] [Abstract][Full Text] [Related]
24. Umeclidinium in patients with COPD: a randomised, placebo-controlled study. Trivedi R; Richard N; Mehta R; Church A Eur Respir J; 2014 Jan; 43(1):72-81. PubMed ID: 23949963 [TBL] [Abstract][Full Text] [Related]
25. [Chronic obstructive pulmonary disease (COPD): diagnosis and treatment]. Kardos P Dtsch Med Wochenschr; 2004 Mar; 129(10):490-3. PubMed ID: 14986237 [No Abstract] [Full Text] [Related]
26. Dose response of umeclidinium administered once or twice daily in patients with COPD: a pooled analysis of two randomized, double-blind, placebo-controlled studies. Donohue JF; Kalberg C; Shah P; Beerahee M; Mehta R; Gunawan R; Church A J Clin Pharmacol; 2014 Nov; 54(11):1214-20. PubMed ID: 24895108 [TBL] [Abstract][Full Text] [Related]
28. [Combinations of bronchodilators in COPD therapy--"fashionable" or rule?]. Mihălţan F Pneumologia; 2013; 62(3):172-5. PubMed ID: 24274002 [TBL] [Abstract][Full Text] [Related]
29. [Clinical benefits of tiotropium, a new anticholinergic bronchodilator]. Izquierdo Alonso JL An Med Interna; 2002 Dec; 19(12):640-3. PubMed ID: 12593035 [TBL] [Abstract][Full Text] [Related]
30. [Safety of tiotropium therapy in chronic obstructive lung diseases (COPD)]. Osztovits J; Fehér J Orv Hetil; 2010 May; 151(18):749-50. PubMed ID: 20410002 [No Abstract] [Full Text] [Related]
32. [The new COPD guidelines reviewed. Smoking cessation--and what else?]. Wepner U MMW Fortschr Med; 2003 Feb; 145(8):6-8. PubMed ID: 12661433 [No Abstract] [Full Text] [Related]
33. [Tiotropium bromide: the role in the treatment of chronic obstructive pulmonary diseases]. Sinopal'nikov AI Ter Arkh; 2004; 76(3):27-35. PubMed ID: 15108455 [No Abstract] [Full Text] [Related]
34. [Tiotropium. A new anti-cholinergic agent for treatment of chronic obstructive pulmonary disease]. Pedersen ST; Lange P Ugeskr Laeger; 2003 May; 165(22):2279-83. PubMed ID: 12830753 [TBL] [Abstract][Full Text] [Related]
35. [Pneumology. Should we fear inhaled anticholinergic bronchodilators?]. Rochat T; Janssens JP Rev Med Suisse; 2009 Jan; 5(186):135-7. PubMed ID: 19238933 [TBL] [Abstract][Full Text] [Related]
36. Umeclidinium/vilanterol combination inhaler efficacy and potential impact on current chronic obstructive pulmonary disease management guidelines. Davidson JF; Donohue JF; Ohar JA Expert Opin Drug Saf; 2015 Feb; 14(2):317-24. PubMed ID: 25598422 [TBL] [Abstract][Full Text] [Related]
37. Effects of anticholinergics and beta-agonists in COPD. Hansen-Flaschen J J Gen Intern Med; 2007 Jun; 22(6):893; author reply 894. PubMed ID: 17406953 [No Abstract] [Full Text] [Related]
38. A stepwise approach to management of stable COPD with inhaled pharmacotherapy: a review. Restrepo RD Respir Care; 2009 Aug; 54(8):1058-81. PubMed ID: 19650947 [TBL] [Abstract][Full Text] [Related]
39. [New drug therapy of chronic obstructive pulmonary disease]. Kino H Nihon Rinsho; 2003 Dec; 61(12):2175-80. PubMed ID: 14674329 [TBL] [Abstract][Full Text] [Related]